Screening method, device, and platform for CTC's in blood that utilizes digital holography microscopy, eliminating the need for labeling and allowing for high-throughput.
Primary Application Area: Healthcare & Medical Devices
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
Vetted Programs/Awards: Cancer Prevention Institute of Texas (CPRIT)
Organization Type: Academic/Gov Lab
GOVT/EXTERNAL FUNDING SOURCES
External Funding to Date: Cancer Prevention Institute of Texas (CPRIT) (RP140840) (200k)